Navigation Links
Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
Date:5/15/2013

NASHVILLE, Tenn., May 15, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Healthcare Conference at the Sheraton New York hotel on Monday, May 20, 2013, at 9:30 a.m. Eastern Time.

The presentation will be simultaneously webcast and can be accessed through the Investor Relations section of Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.

 


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter Financial Results
2. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
3. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
4. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
5. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
6. Cumberland Emerging Technologies Expands Life Sciences Center
7. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
8. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
9. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
10. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
11. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... INDIGO Biosciences, Inc. (INDIGO), ... announced the addition of the Human MDR-1 / P-Glycoprotein Drug Interaction Assay ... and allows researchers to perform critical toxicology testing previously available only through contract ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
(Date:6/16/2019)... ... June 15, 2019 , ... Lycotec Ltd, a Cambridge ... study on its new prebiotic, LycoBiotic™, which is 1,000 – 4,000 stronger than ... which were based on a proprietary composition of GA lycopene, specially developed for ...
Breaking Medicine Technology:
(Date:6/16/2019)... ... June 15, 2019 , ... All families go through tough times. When parents ... and lack of a support network, they may be unable to care for their ... the home and place them with a relative, familiar caregiver or foster family while ...
(Date:6/14/2019)... ... June 14, 2019 , ... ... Pink Bag Event® scheduled for Saturday, July 13th. UBCF is thrilled to return ... directly impacted by breast cancer. This second event was added after an overwhelming ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... 30 Second Test (BL30SEC) has been accepted by the 2019 National Conference of ... Appendix N requirements. , The Charm BL30SEC test was validated by third ...
(Date:6/13/2019)... ... ... Hard money lenders like Monroe Funding Corporation are able to respond and approve ... If the documentation and collateral are immediately available, it’s possible to receive approval and ... with a traditional lender, which allows loans to be customized and adjusted based on ...
Breaking Medicine News(10 mins):